Header Logo

Nicholas Moore

TitleAssistant Professor
InstitutionRush University, College of Health Sciences
DepartmentMedical Laboratory Science
Address
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My Scopus ID is 37085372100.

    My ORCID ID is 0000-0002-9734-8905.

    My NIH COMMONS name is NMOORE2.

    My academic profile: https://www.rushu.rush.edu/faculty/nicholas-moore-ms-mlsascpcm

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sullivan E, Macias Jimenez MD, Moore NM. Utilization of an immunochromatographic lateral flow assay for rapid detection of carbapenemase production in gram negative bacilli. Lab Med. 2023 Nov 02; 54(6):e204-e206. PMID: 37658816.
      Citations:    
    2. Anderson M, Hodges A, Luk KC, Olivo A, Forberg K, Meyer TV, Strobel C, Kim M, Toolsie D, Moore NM, Goldstein Y, Rodgers M, Lucic D, Cloherty G. Development and validation of three automated high-throughput molecular tests to detect MPX virus infections. J Infect Dis. 2023 Sep 22. PMID: 37739785.
      Citations:    
    3. Prinzi AM, Moore NM. Change of Plans: Overview of Bacterial Taxonomy, Recent Changes of Medical Importance, and Potential Areas of Impact. Open Forum Infect Dis. 2023 Jul; 10(7):ofad269. PMID: 37408854.
      Citations:    
    4. Kim DY, Lin MY, Jennings C, Li H, Jung JH, Moore NM, Ghinai I, Black SR, Zaccaro DJ, Brofman J, Hayden MK. Duration of Replication-Competent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Shedding Among Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2023 02 08; 76(3):e416-e425. PMID: 35607802.
      Citations:    
    5. Whitney E, Pitrak D, Beavis KG, Moore NM, Shankaran S, Abeleda AP, Schmitt J, Sha BE. Utility of the Signal-to-Cutoff Ratio and Antigen Index from Fourth- and Fifth-Generation HIV-1/HIV-2 Antigen/Antibody Assays for the Diagnosis of Acute HIV Infection: Applicability for Real-Time Use for Immediate Initiation of Antiretroviral Therapy. J Clin Microbiol. 2022 12 21; 60(12):e0120422. PMID: 36448814.
      Citations:    
    6. Sansom SE, Barbian H, Hayden MK, Fukuda C, Moore NM, Thotapalli L, Baied EJ, Kim DY, Snitkin E, Lin MY. Genomic Investigation to Identify Sources of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Healthcare Personnel in an Acute Care Hospital. Open Forum Infect Dis. 2022 Nov; 9(11):ofac581. PMID: 36467294.
      Citations:    
    7. Sansom SE, Logan LK, Green SJ, Moore NM, Hayden MK. Whole-genome sequencing for neonatal intensive care unit outbreak investigations: Insights and lessons learned - ADDENDUM. Antimicrob Steward Healthc Epidemiol. 2021; 1(1):e18. PMID: 36169403.
      Citations:    
    8. Sansom SE, Logan LK, Green SJ, Moore NM, Hayden MK. Whole-genome sequencing for neonatal intensive care unit outbreak investigations: Insights and lessons learned. Antimicrob Steward Healthc Epidemiol. 2021; 1(1):e2. PMID: 36168459.
      Citations:    
    9. Moore NM, Li H, Schejbal D, Lindsley J, Hayden MK. Comparison of Two Commercial Molecular Tests and a Laboratory-Developed Modification of the CDC 2019-nCoV Reverse Transcriptase PCR Assay for the Detection of SARS-CoV-2. J Clin Microbiol. 2020 07 23; 58(8). PMID: 32461287.
      Citations:    
    10. Grennan D, Varughese C, Moore NM. Medications for Treating Infection. JAMA. 2020 01 07; 323(1):100. PMID: 31910281.
      Citations:    
    11. Shimasaki T, Seekatz A, Bassis C, Rhee Y, Yelin RD, Fogg L, Dangana T, Cisneros EC, Weinstein RA, Okamoto K, Lolans K, Schoeny M, Lin MY, Moore NM, Young VB, Hayden MK. Increased Relative Abundance of Klebsiella pneumoniae Carbapenemase-producing Klebsiella pneumoniae Within the Gut Microbiota Is Associated With Risk of Bloodstream Infection in Long-term Acute Care Hospital Patients. Clin Infect Dis. 2019 05 30; 68(12):2053-2059. PMID: 30239622.
      Citations:    
    12. Seekatz AM, Bassis CM, Fogg L, Moore NM, Rhee Y, Lolans K, Weinstein RA, Lin MY, Young VB, Hayden MK. Gut Microbiota and Clinical Features Distinguish Colonization With Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae at the Time of Admission to a Long-term Acute Care Hospital. Open Forum Infect Dis. 2018 Aug; 5(8):ofy190. PMID: 30151415.
      Citations:    
    13. Traczewski MM, Carretto E, Canton R, Moore NM. Multicenter Evaluation of the Xpert Carba-R Assay for Detection of Carbapenemase Genes in Gram-Negative Isolates. J Clin Microbiol. 2018 08; 56(8). PMID: 29848561.
      Citations:    
    14. Moore NM, Proia LA. Severe acute respiratory distress syndrome in a liver transplant patient. Med Mycol Case Rep. 2018 Sep; 21:1-3. PMID: 29984146.
      Citations:    
    15. Moore NM, Cant?n R, Carretto E, Peterson LR, Sautter RL, Traczewski MM. Rapid Identification of Five Classes of Carbapenem Resistance Genes Directly from Rectal Swabs by Use of the Xpert Carba-R Assay. J Clin Microbiol. 2017 07; 55(7):2268-2275. PMID: 28515213.
      Citations:    
    16. Okamoto K, Lin MY, Haverkate M, Lolans K, Moore NM, Weiner S, Lyles RD, Blom D, Rhee Y, Kemble S, Fogg L, Hines DW, Weinstein RA, Hayden MK. Modifiable Risk Factors for the Spread of Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Among Long-Term Acute-Care Hospital Patients. Infect Control Hosp Epidemiol. 2017 06; 38(6):670-677. PMID: 28397615.
      Citations:    
    17. Bassis CM, Moore NM, Lolans K, Seekatz AM, Weinstein RA, Young VB, Hayden MK. Comparison of stool versus rectal swab samples and storage conditions on bacterial community profiles. BMC Microbiol. 2017 03 31; 17(1):78. PMID: 28359329.
      Citations:    
    18. Haverkate MR, Weiner S, Lolans K, Moore NM, Weinstein RA, Bonten MJ, Hayden MK, Bootsma MC. Duration of Colonization With Klebsiella pneumoniae Carbapenemase-Producing Bacteria at Long-Term Acute Care Hospitals in Chicago, Illinois. Open Forum Infect Dis. 2016 Oct; 3(4):ofw178. PMID: 27747253.
      Citations:    
    19. Haverkate MR, Bootsma MC, Weiner S, Blom D, Lin MY, Lolans K, Moore NM, Lyles RD, Weinstein RA, Bonten MJ, Hayden MK. Modeling spread of KPC-producing bacteria in long-term acute care hospitals in the Chicago region, USA. Infect Control Hosp Epidemiol. 2015 Oct; 36(10):1148-54. PMID: 26204992.
      Citations:    
    20. Hayden MK, Lin MY, Lolans K, Weiner S, Blom D, Moore NM, Fogg L, Henry D, Lyles R, Thurlow C, Sikka M, Hines D, Weinstein RA. Prevention of colonization and infection by Klebsiella pneumoniae carbapenemase-producing enterobacteriaceae in long-term acute-care hospitals. Clin Infect Dis. 2015 Apr 15; 60(8):1153-61. PMID: 25537877.
      Citations:    
    21. Lyles RD, Moore NM, Weiner SB, Sikka M, Lin MY, Weinstein RA, Hayden MK, Sinkowitz-Cochran RL. Understanding staff perceptions about Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae control efforts in Chicago long-term acute care hospitals. Infect Control Hosp Epidemiol. 2014 Apr; 35(4):367-74. PMID: 24602941.
      Citations:    
    22. Moore NM, Flaws ML. Antimicrobial resistance mechanisms in Pseudomonas aeruginosa. Clin Lab Sci. 2011; 24(1):47-51. PMID: 21404965.
      Citations:    
    23. Moore NM, Flaws ML. Introduction: Pseudomonas aeruginosa. Clin Lab Sci. 2011; 24(1):41-2. PMID: 21404963.
      Citations:    
    24. Moore NM, Flaws ML. Treatment strategies and recommendations for Pseudomonas aeruginosa infections. Clin Lab Sci. 2011; 24(1):52-6. PMID: 21404966.
      Citations:    
    25. Moore NM, Flaws ML. Epidemiology and pathogenesis of Pseudomonas aeruginosa infections. Clin Lab Sci. 2011; 24(1):43-6. PMID: 21404964.
      Citations:    
    Moore's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (96)
    Explore
    _
    Co-Authors (8)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _